1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Ortho-McNeil

Anonymous company board for Ortho-McNeil


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    31
    Views:
    16,377
  2. Anonymous
    Replies:
    62
    Views:
    52,441
  3. Anonymous
    Replies:
    64
    Views:
    22,775
  4. Anonymous
    Replies:
    15
    Views:
    13,663
  5. Anonymous
    Replies:
    10
    Views:
    11,703
  6. Anonymous
    Replies:
    5
    Views:
    5,110
  7. rph
    Replies:
    1
    Views:
    3,000
  8. Anonymous
    Replies:
    27
    Views:
    11,956
  9. Anonymous
    Replies:
    27
    Views:
    9,478
  10. Anonymous
    Replies:
    0
    Views:
    2,628
  11. Anonymous
    Replies:
    4
    Views:
    3,406
  12. Anonymous
    Replies:
    11
    Views:
    4,496
  13. Anonymous
    Replies:
    2
    Views:
    3,220
  14. Anonymous
    Replies:
    13
    Views:
    5,362
  15. Anonymous
    Replies:
    11
    Views:
    4,481
  16. Anonymous
    Replies:
    23
    Views:
    7,296
  17. Paul Revere
    Replies:
    2
    Views:
    3,013
  18. Paul Revere
    Replies:
    398
    Views:
    107,275
  19. Anonymous
    Replies:
    289
    Views:
    70,643
  20. Anonymous
    Replies:
    0
    Views:
    3,032

Thread Display Options

Loading...